Hepatitis b and Hyperammonaemia

Summary:

Hyperammonaemia is found among people with Hepatitis b, especially for people who are male, 60+ old.

The study analyzes which people have Hyperammonaemia with Hepatitis b. It is created by eHealthMe based on reports of 19 people who have Hepatitis b from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatitis b?

Hepatitis b is found to be associated with 515 drugs and 683 conditions by eHealthMe. Check the latest studies of Hepatitis b.

What is Hyperammonaemia?

Hyperammonaemia is found to be associated with 397 drugs and 562 conditions by eHealthMe. Check the latest studies of Hyperammonaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

19 people who have Hepatitis B and Hyperammonaemia are studied.

Would you have Hyperammonaemia when you have Hepatitis b?

Gender of people who have Hepatitis B and experienced Hyperammonaemia *:

female: 50 %
male: 50 %

Age of people who have Hepatitis B and experienced Hyperammonaemia *:

Common co-existing conditions for these people *:

High Blood Pressure: 5 people, 26.32%
Insomnia (sleeplessness): 2 people, 10.53%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 10.53%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 10.53%
Disease Complication: 2 people, 10.53%
Dementia With Lewy Bodies (progressive degenerative disease or syndrome of the brain): 2 people, 10.53%
Hiv Infection: 1 person, 5.26%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 5.26%
Breast Cancer Metastatic: 1 person, 5.26%

Common drugs taken by these people *:

Common symptoms for these people *:

Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 6 people, 31.58%
Acute Kidney Failure: 5 people, 26.32%
Altered State Of Consciousness (altered state of mind): 5 people, 26.32%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 5 people, 26.32%
Nosebleed (bleeding from nose): 3 people, 15.79%
Liver Disorder (liver diseases): 3 people, 15.79%
Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases): 3 people, 15.79%
Hyperglycemia (high blood sugar): 3 people, 15.79%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 10.53%
Aspartate Aminotransferase Increased: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperammonaemia?

- Check whether Hyperammonaemia is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Hepatitis b (21,088 reports)
Hyperammonaemia (6,053 reports)

All the drugs that are associated with Hyperammonaemia:

Hyperammonaemia (397 drugs)

All the conditions that are associated with Hyperammonaemia:

Hyperammonaemia (562 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperammonaemia and Hepatitis b, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.